相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases
Antonio Cuadrado
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
Olmo Martin-Camara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention
Stephanie M. Boas et al.
ANTIOXIDANTS (2022)
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
Liaisan Arslanbaeva et al.
MOLECULES (2022)
Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy
Mukesh Gautam et al.
SCIENTIFIC REPORTS (2022)
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Sibel Suzen et al.
PHARMACEUTICALS (2022)
Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders
Elizabeth Minj et al.
CURRENT MOLECULAR MEDICINE (2021)
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Silvia Bono et al.
MOLECULAR NEURODEGENERATION (2021)
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis
Carmen Rodriguez-Cueto et al.
BRAIN PATHOLOGY (2021)
Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy
Isabel Lastres-Becker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour
Carlos Vicente-Gutierrez et al.
REDOX BIOLOGY (2021)
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
M. Galan-Ganga et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
Emilia Zgorzynska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Yevgeniya A. Abramzon et al.
FRONTIERS IN NEUROSCIENCE (2020)
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
Loreto Martinez-Gonzalez et al.
SCIENTIFIC REPORTS (2020)
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Liam Baird et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
Amyotrophic lateral sclerosis: a clinical review
P. Masrori et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies
Shon A. Koren et al.
NEUROBIOLOGY OF DISEASE (2020)
Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis
Francisco Espejo-Porras et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The role of Nrf2 signaling in counteracting neurodegenerative diseases
Albena T. Dinkova-Kostova et al.
FEBS JOURNAL (2018)
Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy.
Antonio Cuadrado et al.
REDOX BIOLOGY (2018)
Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
Gwendoline Montes Diaz et al.
AUTOIMMUNITY REVIEWS (2018)
Frontotemporal dementia: latest evidence and clinical implications
Juan Joseph Young et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway
Diane Moujalled et al.
HUMAN MOLECULAR GENETICS (2017)
ALS and frontotemporal dementia belong to a common disease spectrum
P. Couratier et al.
REVUE NEUROLOGIQUE (2017)
Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch
David Ross et al.
FRONTIERS IN PHYSIOLOGY (2017)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder
Fen-Biao Gao et al.
EMBO JOURNAL (2017)
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Isabel Lastres-Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes
Irene Lopez-Fabuel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Emma L. Scotter et al.
NEUROTHERAPEUTICS (2015)
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
Roberto Bomprezzi
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Isabel Lastres-Becker et al.
BRAIN (2014)
Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis
Petra Bergstrom et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
The Predicted Molecular Weight of Nrf2: It Is What It Is Not
Alexandria Lau et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
Emanuele D'Amico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Correction: Absence of Nrf2 or Its Selective Overexpression in Neurons and Muscle Does Not Affect Survival in ALS-Linked Mutant hSOD1 Mouse Models
Marcelo R. Vargas et al.
PLoS One (2013)
Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice
Takafumi Mimoto et al.
BRAIN RESEARCH (2012)
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
Isabel Lastres-Becker et al.
HUMAN MOLECULAR GENETICS (2012)
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
Todd J. Cohen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
Kuen-Jer Tsai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxidative stress biomarkers in sporadic ALS
Hiroshi Mitsumoto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
TDP-43 A315T mutation in familial motor neuron disease
Michael A. Gitcho et al.
ANNALS OF NEUROLOGY (2008)
The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia
Ian R. A. Mackenzie et al.
CURRENT OPINION IN NEUROLOGY (2008)
ALS and FTLD: two faces of TDP-43 proteinopathy
R. M. Liscic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: Protective role of S-allylcysteine
Esperanza Garcia et al.
FREE RADICAL RESEARCH (2008)
Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis
Alexander Sarlette et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis
Marcelo R. Vargas et al.
JOURNAL OF NEUROSCIENCE (2008)
Continuum of frontal lobe impairment in amyotrophic lateral sclerosis
Jennifer M. Murphy et al.
ARCHIVES OF NEUROLOGY (2007)
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS
J Kirby et al.
BRAIN (2005)
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
C Lomen-Hoerth et al.
NEUROLOGY (2002)
分享论文
